Company / Tangible Book Value per Share
Corcept Therapeutics Incorporated Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.16
FY2025
5-year range
$3.18 / $6.57
FY2021-FY2025
Trend
-6.2%
vs FY2024
Sector context
#87 of 209
Health Care
What the data says
At $6.16, Corcept Therapeutics Incorporated's tangible book value per share ranks #87 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-0.03 in FY2016 to $6.57 in FY2024.
Based on SEC 10-K filings.
6.16 in FY2025 with a 5-year CAGR of +20.7%.
Improved from $4.70 to $6.16 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- +20.7%
- 10-Year CAGR
- -
Sector benchmark
-94.9% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 6.2% year-over-year.
- Ranks #87 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.16 | -6.2% |
| FY2024 | $6.57 | +39.9% |
| FY2023 | $4.70 | -4.9% |
| FY2022 | $4.94 | +55.4% |
| FY2021 | $3.18 | +32.0% |
| FY2020 | $2.41 | +45.1% |
| FY2019 | $1.66 | +360.2% |
| FY2018 | $0.36 | -78.7% |
| FY2017 | $1.69 | +5583.2% |
| FY2016 | -$0.03 | -116.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026